Generation of a parainfluenza virus type 1 vaccine candidate by replacing the HN and F glycoproteins of the live-attenuated PIV3 cp45 vaccine virus with their PIV1 counterparts

Author： H. Skiadopoulos M.   Tao T.   Surman S.R.   Collins P.L.   Murphy B.R.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.18, Iss.5, 1999-10, pp. : 503-510

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A live attenuated recombinant chimeric parainfluenza virus (PIV) candidate vaccine containing the hemagglutinin-neuraminidase and fusion glycoproteins of PIV1 and the remaining proteins from PIV3 induces resistance to PIV1 even in animals immune to P

By Tao T.   Davoodi F.   Cho C.J.   Skiadopoulos M.H.   Durbin A.P.   Collins P.L.   Murphy B.R.  

Vaccine, Vol. 18, Iss. 14, 2000-02 ,pp. : 1359-1366

Elsevier

Access to resources Recommend Favorite

A live attenuated chimeric recombinant parainfluenza virus (PIV) encoding the internal proteins of PIV type 3 and the surface glycoproteins of PIV type 1 induces complete resistance to PIV1 challenge and partial resistance to PIV3 challenge

By Tao T.   Skiadopoulos M.H.   Durbin A.P.   Davoodi F.   Collins P.L.   Murphy B.R.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1100-1108

Elsevier

Access to resources Recommend Favorite

The recombinant chimeric human parainfluenza virus type 1 vaccine candidate, rHPIV3-1cp45, is attenuated, immunogenic, and protective in African green monkeys

By Skiadopoulos M.H.   Tatem J.M.   Surman S.R.   Mitcho Y.   Wu S.-L.   Elkins W.R.   Murphy B.R.  

Vaccine, Vol. 20, Iss. 13, 2002-03 ,pp. : 1846-1852

Elsevier

Access to resources Recommend Favorite

The two amino acid substitutions in the L protein of cpts530/1009, a live-attenuated respiratory syncytial virus candidate vaccine, are independent temperature-sensitive and attenuation mutations

By Juhasz K.   Whitehead S.S.   Boulanger C.A.   Firestone C.-Y.   Collins P.L.   Murphy B.R.  

Vaccine, Vol. 17, Iss. 11, 1999-03 ,pp. : 1416-1424

Elsevier

Access to resources Recommend Favorite

Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate

By Hart M.K.   Caswell-Stephan K.   Bakken R.   Tammariello R.   Pratt W.   Davis N.   Johnston R.E.   Smith J.   Steele K.  

Vaccine, Vol. 18, Iss. 26, 2000-07 ,pp. : 3067-3075

Elsevier

Access to resources Recommend Favorite